April 30th 2025
The company’s intent is to establish Merck Wilmington Biotech as the future United States home for producing Keytruda for US patients.
Chr. Hansen, Lonza Joint Venture Gets Anti-Trust Nod to Manufacture Live Biotherapeutics
September 3rd 2019The joint venture, named BacThera, will operate out of headquarters in Basel, Switzerland and will serve pre-clinical to Phase II projects, with the ability to expand to Phase III and commercial manufacturing in the future.